Clinical Trials
4 trialsNCT07217587 2026-06-05
EPIC
Janssen Research & Development, LLC
Phase 3 Recruiting
NCT07072988 2025-09-24
OPTIMAGE
Centre Hospitalier Universitaire de Nice
Phase 4 Recruiting
NCT06765161 2025-07-29
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
Clinique Neuro-Outaouais
Phase 3 Recruiting
NCT06587867 2024-09-19
Seronegative Myasthenia Gravis - Efgartigimod IV
University Health Network, Toronto
Phase 3 Recruiting